Darren Sherman - 28 Jan 2026 Form 4 Insider Report for Orchestra BioMed Holdings, Inc. (OBIO)

Role
President and Chief Operating Officer, Director
Signature
/s/ Andrew Taylor, Attorney-in-Fact
Issuer symbol
OBIO
Transactions as of
28 Jan 2026
Net transactions value
$0
Form type
4
Filing time
06 Feb 2026, 16:15:16 UTC
Previous filing
02 Jan 2026
Next filing
13 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Sherman Darren President and Chief Operating Officer, Director C/O ORCHESTRA BIOMED HOLDINGS, INC., 150 UNION SQUARE DRIVE, NEW HOPE /s/ Andrew Taylor, Attorney-in-Fact 06 Feb 2026 0001723524

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OBIO Stock Option Award $0 +34,974 $0.000000 34,974 28 Jan 2026 Common Stock 34,974 $2.85 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This date represents the date of vesting of a performance stock option granted on April 23, 2025.
F2 The stock option vests over a four-year period as follows: 25% on the April 23, 2026 (the "Vesting Commencement Date") with the remaining 75% vesting in equal installments every three months thereafter on the same day of the month as the Vesting Commencement Date over a three-year period, commencing in the third month after the Vesting Commencement Date.

Remarks:

President and Chief Operating Officer